about
Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strainsPotential anti-HPV and related cancer agents from marine resources: an overview.Human papillomaviruses as therapeutic targets in human cancer.Protein transduction domain can enhance the humoral immunity and cross-protection of HPV16L2 peptide vaccinesRole of L2 cysteines in papillomavirus infection and neutralizationDevelopment of human papillomavirus chimaeric L1/L2 candidate vaccines.
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The future of vaccines for cervical cancer.
@ast
The future of vaccines for cervical cancer.
@en
type
label
The future of vaccines for cervical cancer.
@ast
The future of vaccines for cervical cancer.
@en
prefLabel
The future of vaccines for cervical cancer.
@ast
The future of vaccines for cervical cancer.
@en
P2860
P1433
P1476
The future of vaccines for cervical cancer.
@en
P2093
Richard B S Roden
Warner K Huh
P2860
P304
P356
10.1016/J.YGYNO.2008.01.004
P407
P433
P577
2008-05-01T00:00:00Z